image
Healthcare - Biotechnology - NASDAQ - US
$ 5.53
4.34 %
$ 291 M
Market Cap
-1.52
P/E
CASH FLOW STATEMENT
-154 M OPERATING CASH FLOW
25.32%
249 M INVESTING CASH FLOW
174.06%
31 K FINANCING CASH FLOW
1535.88%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Kodiak Sciences Inc.
image
Net Income -260 M
Depreciation & Amortization 25.9 M
Capital Expenditures -41.4 M
Stock-Based Compensation 88.6 M
Change in Working Capital -7.36 M
Others -13.8 M
Free Cash Flow -196 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (260.5) (333.8) (267.0) (133.1) (47.4) (41.4) (27.9) (17.1)
Depreciation & Amortization 25.9 11.0 8.7 4.2 0.9 0.5 0.5 0.3
Deferred Income Tax 0 0 0.1 51 K 0 10.2 1.3 0
Stock Based Compensation 88.6 106.0 61.4 30.7 6.1 2.7 0.3 0.3
Other Operating Activities (0.8) (1.6) 53 K 49 K (0.2) 5.5 1.2 0.8
Change in Working Capital (7.4) 12.0 14.4 14.8 1.4 (6.4) 7.0 0.6
Cash From Operations (154.2) (206.5) (182.3) (83.4) (39.1) (29.0) (17.7) (16.0)
INVESTING CASH FLOW
Capital Expenditures (41.4) (47.4) (63.3) (7.0) (0.4) (0.6) (0.2) (0.8)
Other Items 290.7 (289.1) 24.5 111.8 (136.6) 0 0 0
Cash From Investing Activities 249.2 (336.5) (38.8) 104.8 (137.0) (0.6) (0.2) (0.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0.2 0.5 (0.5) (0.1) 0 0 0
Total Debt Repaid 0 0 0 5 K 48 K 32.9 9.9 62 K
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 31 K 1.9 8.2 105.9 2.3 (0.2) (0.3) 58 K
Cash From Financing Activities 31 K 1.9 K 8.18 K 717.4 299.7 116.5 9.6 (0.1)
CHANGE IN CASH
Net Change In Cash 95.1 (541.1) (212.9) 738.8 123.5 86.9 (8.2) (16.9)
FREE CASH FLOW
Free Cash Flow (195.6) (253.8) (245.6) (90.4) (39.6) (29.6) (17.9) (16.8)